Skip to main content

Advertisement

SpringerLink
Log in

The detection and clinical significance of peripheral regulatory CD4+CD25hiCD127low T cells in patients with non-small cell lung cancer

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Objective

In this study, we aimed to discuss the clinical significance of CD4+CD25hiCD127low regulatory T cells (Tregs) in the peripheral blood of patients with non-small cell lung cancer (NSCLC).

Methods

Sixty patients with NSCLC and 35 healthy controls were studied. Peripheral blood CD4+CD25hiCD127lowTregs, CD4+CD25hiT cells, and CD4+T cells were measured with flow cytometric analysis, and results were compared between the groups.

Results

Compared with healthy people, CD4+CD25hiCD127low Tregs and CD4+CD25hi T cells significantly increased in patients with NSCLC, while CD4+ T cell proportions decreased.

Conclusions

CD4+CD25 hi CD127low Treg detection in the peripheral blood of NSCLC patients is highly significant, in that it provides additional knowledge to guide the selection of individualized treatment plans for patients with NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Zhou J, Min Z, Zhang D, Wang W, Marincola F, Wang X. Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer. J Transl Med. 2014;12:304. https://doi.org/10.1186/s12967-014-0304-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995;186(7):3808–21 (Baltimore, Md: 1950. 2011).

    Google Scholar 

  3. Liu C, Workman CJ, Vignali DA. Targeting regulatory T cells in tumors. FEBS J. 2016;283(14):2731–48. https://doi.org/10.1111/febs.13656.

    Article  CAS  PubMed  Google Scholar 

  4. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8(7):523–32. https://doi.org/10.1038/nri2343.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Baecher-Allan C, Viglietta V, Hafler DA. Human CD4 + CD25 + regulatory T cells. Semin Immunol. 2004;16(2):89–98. https://doi.org/10.1016/j.smim.2003.12.005.

    Article  CAS  PubMed  Google Scholar 

  6. Chen Z, Ding J, Pang N, Du R, Meng W, Zhu Y, et al. The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. Diagn Pathol. 2013;8:61. https://doi.org/10.1186/1746-1596-8-61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol (Baltimore, Md: 1950). 2002;168(9):4272–6.

    Article  CAS  Google Scholar 

  8. Islas-Vazquez L, Prado-Garcia H, Aguilar-Cazares D, Meneses-Flores M, Galicia-Velasco M, Romero-Garcia S, et al. LAP TGF-beta subset of CD4(+)CD25(+)CD127(-) treg cells is increased and overexpresses LAP TGF-beta in lung adenocarcinoma patients. Biomed Res Int. 2015;2015:430943. https://doi.org/10.1155/2015/430943.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wang J, Yang J. Identification of CD4(+)CD25(+)CD127(-) regulatory T cells and CD14(+)HLA(-)DR(-)/low myeloid-derived suppressor cells and their roles in the prognosis of breast cancer. Biomed Rep. 2016;5(2):208–12. https://doi.org/10.3892/br.2016.694.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ellis GI, Reneer MC, Velez-Ortega AC, McCool A, Marti F. Generation of induced regulatory T cells from primary human naive and memory T cells. J Vis Exp. 2012. https://doi.org/10.3791/3738.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Angin M, King M, Addo MM. New tools to expand regulatory T cells from HIV-1-infected individuals. J Vis Exp. 2013;75:e50244. https://doi.org/10.3791/50244.

    Article  CAS  Google Scholar 

  12. Kono K, Kawaida H, Takahashi A, Sugai H, Mimura K, Miyagawa N, et al. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother. 2006;55(9):1064–71. https://doi.org/10.1007/s00262-005-0092-8.

    Article  CAS  PubMed  Google Scholar 

  13. Peguillet I, Milder M, Louis D, Vincent-Salomon A, Dorval T, Piperno-Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Can Res. 2014;74(8):2204–16. https://doi.org/10.1158/0008-5472.Can-13-2269.

    Article  CAS  Google Scholar 

  14. Sharma S, Khosla R, David P, Rastogi A, Vyas A, Singh D, et al. CD4 + CD25 + CD127(low) regulatory T cells play predominant anti-tumor suppressive role in hepatitis B virus-associated hepatocellular carcinoma. Front Immunol. 2015;6:49. https://doi.org/10.3389/fimmu.2015.00049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhong A, Pan X, Shi M. Expression of PD-1 by CD4(+)CD25(+)CD127(low) Treg cells in the peripheral blood of lung cancer patients. OncoTargets Ther. 2015;8:1831–3. https://doi.org/10.2147/ott.S90538.

    Article  CAS  Google Scholar 

  16. Rabe H, Nordstrom I, Andersson K, Lundell AC, Rudin A. Staphylococcus aureus convert neonatal conventional CD4(+) T cells into FOXP3(+) CD25(+) CD127(low) T cells via the PD-1/PD-L1 axis. Immunology. 2014;141(3):467–81. https://doi.org/10.1111/imm.12209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This project was supported by projects of the Suzhou industrial technology innovation (applied basic research of the people’s Livelihood technology and applied health care), Digestive Diseases and Nutrition Research Key Laboratory of Suzhou and Youth Project of Health and Family Planning Bureau of Suzhou High-tech Zone. The project numbers were SYSD2016062, SZS201620, and 2017Q005 respectively.

Author information

Author notes

  1. J. Qiu and G. Che contributed equally to this work.

Authors and Affiliations

  1. Department of Oncology, The Affiliated Suzhou Hospital (West District) of Nanjing Medical University, Suzhou Science and Technology Town Hospital, Suzhou, 215153, China

    J. Qiu & L. Feng

  2. Department of Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519000, Guangdong, China

    G. Che & H. Ma

  3. Department of Cardiothoracic Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Science and Technology Town Hospital, Suzhou, 215153, Jiangsu, China

    F. Liu

  4. Department of Oncology, Hongze Huaian District People’s Hospital, Huaian, 223100, Jiangsu, China

    X. Sha

  5. Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215006, Jiangsu, China

    S. Ju

Authors
  1. J. Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Che
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X. Sha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Ju
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to H. Ma or L. Feng.

Ethics declarations

Conflict of interest

All authors declared that they had no conflict of interest.

Ethical approval

All procedures performed in this study which involved human participants were conformed to the ethical standards of the institutional and/or national research committee and to the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qiu, J., Che, G., Liu, F. et al. The detection and clinical significance of peripheral regulatory CD4+CD25hiCD127low T cells in patients with non-small cell lung cancer. Clin Transl Oncol 21, 1343–1347 (2019). https://doi.org/10.1007/s12094-019-02063-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-019-02063-5

Keywords

Search

Navigation